Show simple item record

dc.contributor.authorGiampaolo, S
dc.contributor.authorWójcik, G
dc.contributor.authorKlein-Hessling, S
dc.contributor.authorSerfling, E
dc.contributor.authorPatra, AK
dc.date.accessioned2018-05-14T13:06:41Z
dc.date.issued2018-02-09
dc.identifier.issn1949-2553
dc.identifier.issn1949-2553
dc.identifier.urihttp://hdl.handle.net/10026.1/11500
dc.description.abstract

The role of NFAT family transcription factors in erythropoiesis is so far unknown, although their involvement has been suggested previously. We have shown recently that Il2-/- mice develop severe anemia due to defects in KLF1 activity during BM erythropoiesis. Although, KLF1 activity is indispensable for erythropoiesis, the molecular details of Klf1 expression have not yet been elucidated. Here we show that an enhanced NFATc1 activity induced by increased integrin-cAMP signaling plays a critical role in the dysregulation of Klf1 expression and thereby cause anemia in Il2-/- mice. Interestingly, enhanced NFATc1 activity augmented apoptosis of immature erythrocytes in Il2-/- mice. On the other hand, ablation of NFATc1 activity enhanced differentiation of Ter119+ cells in BM. Restoring IL-2 signaling in Il2-/- mice reversed the increase in cAMP-NFAT signaling and facilitated normal erythropoiesis. Altogether, our study identified an NFAT-mediated negative signaling axis, manipulation of which could facilitate erythropoiesis and prevent anemia development.

dc.format.extent9632-9644
dc.format.mediumElectronic-eCollection
dc.languageen
dc.language.isoen
dc.publisherImpact Journals, LLC
dc.subjectIL-2
dc.subjectanemia
dc.subjectcAMP
dc.subjecterythropoiesis
dc.subjectintegrin
dc.titleNFAT-mediated defects in erythropoiesis cause anemia in Il2-/- mice.
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/29515759
plymouth.issue11
plymouth.volume9
plymouth.publication-statusPublished
plymouth.journalOncotarget
dc.identifier.doi10.18632/oncotarget.23745
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/Peninsula Medical School
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited States
dcterms.dateAccepted2017-11-09
dc.rights.embargodate2018-6-15
dc.identifier.eissn1949-2553
dc.rights.embargoperiodNo embargo
rioxxterms.versionofrecord10.18632/oncotarget.23745
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-02-09
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV